Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company developing set-point vaccines to prevent serious infectious diseases, today announced that it has secured over US$11 million in a Series A round. Vickers Venture Partners (‘Vickers’), a top-ranked global early stage Venture Capital company led the round and Dr. Finian Tan, Chairman of Vickers Venture … [Read more...] about Emergex Raises More Than US$11 Million in a Series A Round to Progress Its Pipeline of Set-Point Vaccines for Infectious Diseases